C07K 14/6555
At least 1 amino acid in d-form
Official title: {at least 1 amino acid in D-form}
C07K14/6555 (At least 1 amino acid in d-form) appears on 231 US grants and 71 published applications in this corpus.
Search patents in C07K- Granted patents
- 231
- Published applications
- 71
- Assignees
- 78
- Inventors
- 320
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 9 | 0 |
| 1978 | 13 | 0 |
| 1979 | 10 | 0 |
| 1980 | 19 | 0 |
| 1981 | 5 | 0 |
| 1982 | 9 | 0 |
| 1983 | 5 | 0 |
| 1984 | 8 | 0 |
| 1985 | 5 | 0 |
| 1986 | 5 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 7 | 0 |
| 1997 | 7 | 0 |
| 1998 | 22 | 0 |
| 1999 | 14 | 0 |
| 2000 | 6 | 0 |
| 2001 | 8 | 1 |
| 2002 | 6 | 3 |
| 2003 | 2 | 4 |
| 2004 | 3 | 7 |
| 2005 | 3 | 4 |
| 2006 | 7 | 6 |
| 2007 | 2 | 4 |
| 2008 | 0 | 7 |
| 2009 | 5 | 4 |
| 2010 | 2 | 7 |
| 2011 | 1 | 2 |
| 2012 | 3 | 2 |
| 2013 | 6 | 4 |
| 2014 | 2 | 5 |
| 2015 | 8 | 3 |
| 2016 | 3 | 3 |
| 2017 | 2 | 1 |
| 2018 | 2 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cortistatin analogues for the treatment of inflammatory and/or immune diseases13 May 2025US 12,297,294 B2Bcn Peptides, S.A.
- Somatostatin prodrugs1 Mar 2022US 11,261,215 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Backbone-cyclized peptidomimetics with GLP-1R modulating activity4 Aug 2020US 10,730,911 B2Polyphor AG
- Glycosylated polypeptide and drug composition containing said polypeptide10 Apr 2018US 9,937,264 B2Glytech, Inc.
- Somatostatin analogs with inhibitory activity to growth hormone release20 Mar 2018US 9,919,065 B2The Regents of the University of California
- Method for Synthesizing Amide and/or Polypeptide Using Temporary Protected Amino Acid as Ammonia Component1 Jan 2026US 2026/0001906 A1Guangzhou Medical University
- Somatostatin prodrugs20 Aug 2020US 2020/0262871 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Methods and compositions related to improving properties of pharmacological agents targeting nervous system29 Nov 2018US 2018/0340012 A1University of Utah Research Foundation
- Backbone-cyclized peptidomimetics with glp-1r modulating activity15 Mar 2018US 2018/0072774 A1Polyphor AG
- Glycosylated Polypeptide and Drug Composition Containing said Polypeptide8 Jun 2017US 2017/0157260 A1Glytech, Inc.
Most cited
By later US patents
- Cyclic polypeptides having mu-receptor specificity118US 4,684,620 AGibson-Stephens Neuropharmaceuticals, Inc. · 1987
- Therapeutic somatostatin analogs99US 4,853,371 AThe Administrators of the Tulane Educational Fund · 1989
- Stem cell immobilization76US 5,912,177 ACommon Services Agency · 1999
- Conformationally constrained backbone cyclized peptide analogs73US 5,874,529 APeptor Limited · 1999
- Extended N-terminal somatostatin65US 4,316,891 AThe Salk Institute for Biological Studies · 1982